We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Flags FDA’s ‘Untapped’ Authority to Fight High Prices and REMS Abuses
Gottlieb Flags FDA’s ‘Untapped’ Authority to Fight High Prices and REMS Abuses
FDA Commissioner Scott Gottlieb updated lawmakers Thursday on the agency’s plan to help lower drug prices using its “untapped authority” to increase competition and streamline generic drug approvals.
